Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Booth

Showing results (251-260 of 349) with videos related to

Pageof 35
Sort By:
Clinical Genitourinary Cancer|July 5, 2014
A phase II study of GW786034 (pazopanib) with or without bicalutamide in patients with castration-resistant prostate cancerSrikala S Sridhar, Anthony M Joshua, Richard Gregg, et al.
Current Oncology (Toronto, Ont.)|April 30, 2021
Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled TrialsShubham Sharma, J Connor Wells, Wilma M Hopman, et al.
JCO Global Oncology|June 17, 2021
Tracking the Workforce 2020-2030: Making the Case for a Cancer Workforce RegistryArchita Srivastava, Matthew Jalink, Fabio Ynoe de Moraes, et al.
The Lancet. Oncology|June 3, 2023
Global application of National Comprehensive Cancer Network resource-stratified guidelines for systemic treatment of colon cancer: a population-based, customisable model for cost, demand, and procurementBrooke E Wilson, Christopher M Booth, Richard Sullivan, et al.
The Oncologist|July 24, 2024
Patients' considerations of time toxicity when assessing cancer treatments with marginal benefitArjun Gupta, Michael D Brundage, Jacqueline Galica, et al.
The Oncologist|September 23, 2023
Breast Cancer-Related Financial Toxicity in Sri Lanka: Insights From a Lower Middle-Income Country With Free Universal Public HealthcareSarith Ranawaka, Sathika Gunarathna, Sanjeeva Gunasekera, et al.
JNCI Cancer Spectrum|February 21, 2026
Oncologist perspectives on the time toxicity of palliative systemic treatments for advanced cancerSamuel X Stevens, Isaac Y Addo, Ella El-Katateny, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2017
Setting Quality Improvement Priorities for Women Receiving Systemic Therapy for Early-Stage Breast Cancer by Using Population-Level Administrative DataKatherine A Enright, Nathan Taback, Melanie Lynn Powis, et al.
JCO Global Oncology|May 27, 2022
Colorectal Cancer Treatment Characteristics and Concordance With Guidelines in Sri Lanka: Results From a Hospital-Based Cancer RegistryDon Thiwanka Wijeratne, Sanjeeva Gunasekara, Christopher M Booth, et al.
Journal of Palliative Care|July 17, 2019
Management of Cancer-Associated Intestinal Obstruction in the Final Year of LifeShaila J Merchant, Susan B Brogly, Christopher M Booth, et al.
Pageof 35

Showing results (251-260 of 349) with videos related to

Sort By:
Pageof 35
Clinical Genitourinary Cancer|July 5, 2014
A phase II study of GW786034 (pazopanib) with or without bicalutamide in patients with castration-resistant prostate cancerSrikala S Sridhar, Anthony M Joshua, Richard Gregg, et al.
Current Oncology (Toronto, Ont.)|April 30, 2021
Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled TrialsShubham Sharma, J Connor Wells, Wilma M Hopman, et al.
JCO Global Oncology|June 17, 2021
Tracking the Workforce 2020-2030: Making the Case for a Cancer Workforce RegistryArchita Srivastava, Matthew Jalink, Fabio Ynoe de Moraes, et al.
The Lancet. Oncology|June 3, 2023
Global application of National Comprehensive Cancer Network resource-stratified guidelines for systemic treatment of colon cancer: a population-based, customisable model for cost, demand, and procurementBrooke E Wilson, Christopher M Booth, Richard Sullivan, et al.
The Oncologist|July 24, 2024
Patients' considerations of time toxicity when assessing cancer treatments with marginal benefitArjun Gupta, Michael D Brundage, Jacqueline Galica, et al.
The Oncologist|September 23, 2023
Breast Cancer-Related Financial Toxicity in Sri Lanka: Insights From a Lower Middle-Income Country With Free Universal Public HealthcareSarith Ranawaka, Sathika Gunarathna, Sanjeeva Gunasekera, et al.
JNCI Cancer Spectrum|February 21, 2026
Oncologist perspectives on the time toxicity of palliative systemic treatments for advanced cancerSamuel X Stevens, Isaac Y Addo, Ella El-Katateny, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2017
Setting Quality Improvement Priorities for Women Receiving Systemic Therapy for Early-Stage Breast Cancer by Using Population-Level Administrative DataKatherine A Enright, Nathan Taback, Melanie Lynn Powis, et al.
JCO Global Oncology|May 27, 2022
Colorectal Cancer Treatment Characteristics and Concordance With Guidelines in Sri Lanka: Results From a Hospital-Based Cancer RegistryDon Thiwanka Wijeratne, Sanjeeva Gunasekara, Christopher M Booth, et al.
Journal of Palliative Care|July 17, 2019
Management of Cancer-Associated Intestinal Obstruction in the Final Year of LifeShaila J Merchant, Susan B Brogly, Christopher M Booth, et al.
Pageof 35